Short-term and long-term modulation of gene expression by antisense therapeutics

This publication has 32 references indexed in Scilit:

• 2′-O,4′-C-ethylene-bridged nucleic acids (ENA): highly nuclease-resistant and thermodynamically stable oligonucleotides for antisense drug
  Bioorganic & Medicinal Chemistry Letters, 2002
• Modification of Alternative Splicing by Antisense Oligonucleotides as a Potential Chemotherapy for Cancer and Other Diseases
  Current Cancer Drug Targets, 2001
• Backbone Modification of Nucleic Acids: Synthesis, Structure and Therapeutic Applications
  Current Medicinal Chemistry, 2001
• 2′-O,4′-C-methylene bridged nucleic acid (2′,4′-BNA)
  Bioorganic & Medicinal Chemistry, 2001
• 2′-O,4′-C-Methylene Bridged Nucleic Acid Modification Promotes Pyrimidine Motif Triplex DNA Formation at Physiological pH
  Journal of Biological Chemistry, 2001
• Heterocyclic Modifications of Oligonucleotides and Antisense Technology
  Antisense and Nucleic Acid Drug Development, 2000
• Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides
  Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1999
• Morpholino antisense oligomers: the case for an RNase H-independent structural type
  Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1999
• 2′-Carbohydrate modifications in antisense oligonucleotide therapy: importance of conformation, configuration and conjugation
  Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1999
• Oligonucleotide N3′→P5′ phosphoramidates as potential therapeutic agents
  Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1999